Nanasaheb D. Thorat,
Joanna Bauer
Elsevier Science
e druk, 2020
9780128200162
Nanomedicines for Breast Cancer Theranostics
Specificaties
Paperback, blz.
|
Engels
Elsevier Science |
2020
ISBN13: 9780128200162
Rubricering
Onderdeel van serie
Micro and Nano Technologies
Levertijd ongeveer 9 werkdagen
Gratis verzonden
Samenvatting
Nanomedicines for Breast Cancer Theranostics addresses the translational aspects and clinical perspectives of breast cancer nanomedicine from a multidisciplinary perspective. The book summarizes research efforts at the preclinical and clinical stage of nanostructures and nanomedicine for dealing with the important challenge of nanomedicine translation in breast cancer theranostics. This book is an important resource for those working in both academia and industry, focusing on hot topics in biomaterials, biomedical engineering, drug delivery and oncology.
Specificaties
Inhoudsopgave
<p>1. Nanomedicine: next generation modality of breast cancer therapeutics<br>2. Physical and Chemical properties of nanostructures<br>3. Biological Perspectives of Hybrid nanostructures<br>4. Novel hybrid nanostructures in breast cancer nanomedicine<br>5. Synergy between nanoparticles and breast cancer theranostics<br>6. Remotely stimulated Nano medicine for breast cancer therapy<br>7. Functional Nanostructures for drug resistant breast cancer theranostics<br>8. Nanomedicine for early diagnosis of breast cancer<br>9. Nanomedicine strategies for chemoresistant breast cancer theranostics<br>10. Cellular Interaction and Toxicity of Nanostructures<br>11. Nano-pharmacokinetics, pharmacodynamics (PK/PD) and clinical relationship<br>12. A New Approach for Cancer Treatment: from Specific Induction of Breast Cancer to Innovative Gold-Nanoparticle Mediated Thermal Therapies<br>13. Development in efficacy assessment in relevant oncology models for breast cancer nanomedicine<br>14. Consensus protocols for animal experimentation and nanomedicine trials at clinical stage in breast cancer<br>15. Current development in toxicity, clinical trials guidelines for regulatory aspects of breast cancer nanomedicines<br>16. Breast cancer nanomedicine market update and other industrial perspectives of nanomedicine</p>